The TOP trial is a parallel, single-blind, randomized, clinical superiority trial, N=1424 that sought to determine whether liberal versus restrictive transfusion strategy after major general and vascular surgery reduces adverse outcomes in high cardiac risk patients.
Sunil Rao, MD on the results.
6 months ago
